Company Profile
Neobe Therapeutics Ltd
13146056•Private Limited With Share Capital
Get Full Access
20/01/2021
5 years
7
8
72110
very low risk
Company Overview
Registration, classification & business activity
Neobe Therapeutics Ltd (13146056) is a private limited with share capital incorporated on 20/01/2021 (5 years old) and registered in cambridge, CB12LA. The company operates under SIC code 72110 - research and experimental development on biotechnology.
At neobe therapeutics we are engineering tumour-colonizing bacteria that will disrupt tumour micro environment barriers and enable immunotherapies in patients with immune-excluded tumours. only around 20% of patients with solid tumors are estimated to currently benefit from immunotherapies. multiple...
Financial Overview
£273.8K
£45.9K
£227.9K
£37.1K
Key Metrics
8
Employees
7
Directors
15
Shareholders
2
PSCs
1
Patents
Board of Directors
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Innovate Grants
This company received a grant of £262808.0 for Engineering A New Versican Remodeling Recombinant Bacterial Product To Enable Immunotherapy Success In Triple Negative Breast Cancer. The project started on 01/05/2022 and ended on 30/04/2024.
This company received a grant of £699917.0 for Pre-Clinical Development Of A Live Biotherapeutic Product Engineered To Remodel Hyaluronic Acid In Solid Tumours To Enable Checkpoint Inhibitor Efficacy. The project started on 01/12/2023 and ended on 28/02/2026.
+1 more grants available
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating